Functional Consequences of Alterations to Ile279, Ile283, Glu284, His285, Phe286, and His288 in the NH2-terminal Part of Transmembrane Helix M3 of the Na+,K+-ATPase
Abstract:Mutations3 Ala displaced the conformational equilibria of dephosphoenzyme and phosphoenzyme in parallel in favor of E 2 and E 2 P, respectively, and showed a unique enhancement of the E 1 P 3 E 2 P transition rate. These effects suggest that M3 undergoes significant rearrangements in relation to E 1 -E 2 and E 1 P-E 2 P conformational changes. Because the E 1 -E 2 and E 1 P-E 2 P conformational equilibria were differentially affected by some of the mutations, the phosphorylated conformations seem to differ sig… Show more
“…1F). In general, the expressed I279A and F286A mutants exhibited enzymatic properties similar to those reported previously (17). Although I279A had much lower vanadate sensitivity, F286A mutant was more sensitive to vanadate than the wild-type ␣1.…”
Section: Discussionsupporting
confidence: 66%
“…As reported (17), vanadate sensitivity of cell lysates from I3 cells was significantly reduced in comparison to that of AAC-19 cells, whereas a large increase was noted in F19 cells (data not shown).…”
Section: Construction Of Cell Linessupporting
confidence: 48%
“…Moreover, these two mutants are from the same transmembrane domain (17). Finally, these two mutants produce more pronounced kinetic changes than most of the other mutants (17). Functional studies of these mutant-expressing cell lines demonstrate that inhibition of conformation transition is sufficient to attenuate the capability of Na/K-ATPase to regulate cellular Src and consequently ligand-induced activation of protein kinase cascades in cultured cells.…”
mentioning
confidence: 94%
“…Prior studies showed that I279A mutation accumulated the pump at the E1 state, whereas F286A mutation increased the E2 state Na/K-ATPase. Moreover, these two mutants are from the same transmembrane domain (17). Finally, these two mutants produce more pronounced kinetic changes than most of the other mutants (17).…”
mentioning
confidence: 98%
“…Prior studies have identified many ␣1 mutants that inhibit the E1/E2 conformational transition by favoring the pump at either E1-or E2-like state (15)(16)(17)(18). These mutants exhibit altered pumping properties.…”
Background:We propose that Na/K-ATPase regulates Src in an E1/E2 conformation-dependent manner. Results: Expression of ␣1 mutants defective in E1/E2 transition altered both basal and stimuli-induced Src regulation. Conclusion: Na/K-ATPase is necessary for dynamic regulation of Src and Src-mediated pathways. Significance: This is the first demonstration that E1/E2 transition-defective mutants can affect both pumping and signaling functions of Na/K-ATPase.
“…1F). In general, the expressed I279A and F286A mutants exhibited enzymatic properties similar to those reported previously (17). Although I279A had much lower vanadate sensitivity, F286A mutant was more sensitive to vanadate than the wild-type ␣1.…”
Section: Discussionsupporting
confidence: 66%
“…As reported (17), vanadate sensitivity of cell lysates from I3 cells was significantly reduced in comparison to that of AAC-19 cells, whereas a large increase was noted in F19 cells (data not shown).…”
Section: Construction Of Cell Linessupporting
confidence: 48%
“…Moreover, these two mutants are from the same transmembrane domain (17). Finally, these two mutants produce more pronounced kinetic changes than most of the other mutants (17). Functional studies of these mutant-expressing cell lines demonstrate that inhibition of conformation transition is sufficient to attenuate the capability of Na/K-ATPase to regulate cellular Src and consequently ligand-induced activation of protein kinase cascades in cultured cells.…”
mentioning
confidence: 94%
“…Prior studies showed that I279A mutation accumulated the pump at the E1 state, whereas F286A mutation increased the E2 state Na/K-ATPase. Moreover, these two mutants are from the same transmembrane domain (17). Finally, these two mutants produce more pronounced kinetic changes than most of the other mutants (17).…”
mentioning
confidence: 98%
“…Prior studies have identified many ␣1 mutants that inhibit the E1/E2 conformational transition by favoring the pump at either E1-or E2-like state (15)(16)(17)(18). These mutants exhibit altered pumping properties.…”
Background:We propose that Na/K-ATPase regulates Src in an E1/E2 conformation-dependent manner. Results: Expression of ␣1 mutants defective in E1/E2 transition altered both basal and stimuli-induced Src regulation. Conclusion: Na/K-ATPase is necessary for dynamic regulation of Src and Src-mediated pathways. Significance: This is the first demonstration that E1/E2 transition-defective mutants can affect both pumping and signaling functions of Na/K-ATPase.
Na,K-ATPase creates transmembrane ion gradients crucial to the function of the central nervous system. The α-subunit of Na,K-ATPase exists as four isoforms (α1-α4). Several neurological phenotypes derive from α3 mutations. The effects of some of these mutations on Na,K-ATPase function have been studied in vitro. Here we discuss the α3 disease mutations as well as information derived from studies of corresponding mutations of α1 in the light of the high-resolution crystal structures of the Na,K-ATPase. A high proportion of the α3 disease mutations occur in the transmembrane sector and nearby regions essential to Na and K binding. In several cases the compromised function can be traced to disturbance of the Na specific binding site III. Recently, a secondary mutation was found to rescue the defective Na binding caused by a disease mutation. A perspective is that it may be possible to develop an efficient pharmaceutical mimicking the rescuing effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.